北达科他州 的 肺癌 临床试验
北达科他州 有 15 项针对 肺癌 的研究正在招募参与者。
北达科他州 的城市
官方研究文本(英文)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Sanford Bismarck Medical Center, Bismarck
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford South University Medical Center, Fargo
- 以及另外 6 项
招募中观察性研究欢迎健康志愿者
40 至 75 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05334069Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
招募中3 期
70 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06096844Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Sanford Bismarck Medical Center, Bismarck
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford Broadway Medical Center, Fargo
- 以及另外 1 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06498635A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0057), Fargo
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06312137A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
- Sanford Fargo Medical Center ( Site 0039), Fargo
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年8月18日 · NCT06731907Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
- 以及另外 1 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月17日 · NCT05624996Integrated Cancer Repository for Cancer Research
- Essentia Health, Fargo
- Trinity Hospital Cancer Care Center, Minot
招募中观察性研究欢迎健康志愿者
19 至 110 岁 · 所有性别 · 更新于 2026年6月29日 · NCT02012699Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Sanford Roger Maris Cancer Center, Fargo
招募中2 期
18 至 70 岁 · 所有性别 · 更新于 2026年6月26日 · NCT04614103Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年6月3日 · NCT05642572Promoting Radon Testing Among Mothers of Young Children
- University of North Dakota Center for Family Medicine, Bismarck Clinic, Bismarck
- University of North Dakota Center for Family Medicine, Minot Clinic, Minot
招募中欢迎健康志愿者
18 岁及以上 · 女性 · 更新于 2026年5月15日 · NCT07591389Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
招募中2 期
18 Minutes · 所有性别 · 更新于 2026年5月5日 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Sanford Bismarck Medical Center, Bismarck
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford Broadway Medical Center, Fargo
- 以及另外 1 项
招募中2/3 期
18 岁及以上 · 所有性别 · 更新于 2026年5月5日 · NCT06616584SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Fargo
招募中观察性研究
所有年龄段 · 所有性别 · 更新于 2025年10月28日 · NCT03452774Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Altru Health System, Grand Forks
招募中观察性研究
50 岁及以上 · 所有性别 · 更新于 2025年8月5日 · NCT06122077数据来自 ClinicalTrials.gov,检索日期:2026年10月5日。每项研究自行设定入选标准,由研究团队决定谁能参与。